Program
Saline Solution
Also written as “0.9% NaCl”, “Saline nasal spray” and “saline solution”.
Its studies are mostly in Conjunctivitis, Allergic · Corneal Edema · Fatigue · Amyloidosis · Bronchiolitis, led by 2 companies.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Eye-yon Medical | 10 open or running | no phasesince Jun 25, 2013 | Jun 25, 2013 | none ahead |
| UVLrx Therapeutics | 10 open or running | no phasesince Jan 8, 2016 | Jan 8, 2016 | none ahead |
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Jun 25, 2013First study: no phase study in Corneal EdemaNew to Eye-yon MedicalEye-yon Medical · NCT01890252 · 9 enrolled · Israel
- Jan 8, 2016UVLrx Therapeutics's first study: no phase study in FatigueNew to UVLrx TherapeuticsUVLrx Therapeutics · NCT02785133 · 3,063 enrolled · United States
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 2 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Led by | Primary completion | Size |
|---|---|---|---|---|---|
| NCT02785133Fatigue · United States | – | Completed | UVLrx Therapeutics | Oct 2016 | 3,063 |
| NCT01890252Corneal Edema · Israel | – | Completed | Eye-yon Medical | Jan 31, 2014 | 9 |
How it is read
Names in the registry
- “0.9% NaCl”, 1 entry
- “Saline nasal spray”, 1 entry
- “saline solution”, 1 entry
- “Normal Saline Solution”, 1 entry
- “Sterile Normal Saline (0.9% NaCl)”, 1 entry
Conditions, from the studies’ own filings
- Conjunctivitis, Allergic, 1 study
- Corneal Edema, 1 study
- Fatigue, 1 study
- Amyloidosis, 1 study
- Bronchiolitis, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.